These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6168693)

  • 1. A C1-inhibitor-complex assay (INCA): a method to detect C1 activation in vitro and in vivo.
    Hack CE; Hannema AJ; Eerenberg-Belmer AJ; Out TA; Aalberse RC
    J Immunol; 1981 Oct; 127(4):1450-3. PubMed ID: 6168693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.
    Nilsson T; Bäck O
    Clin Exp Immunol; 1985 Apr; 60(1):178-82. PubMed ID: 3874014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1 and human platelets. III. Role of C1 subcomponents in platelet aggregation induced by aggregated IgG.
    Wautier JL; Souchon H; Solal LC; Peltier AP; Caen JP
    Immunology; 1976 Oct; 31(4):595-9. PubMed ID: 185144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1).
    Windfuhr JP; Alsenz J; Loos M
    Mol Immunol; 2005 Apr; 42(6):657-63. PubMed ID: 15781109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-independent C1 activation by E. coli.
    Tenner AJ; Ziccardi RJ; Cooper NR
    J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first complement component: evidence for an equilibrium between C1s free in serum and C1s bound in the C1 complex.
    Bartholomew RM; Esser AF
    J Immunol; 1977 Dec; 119(6):1916-22. PubMed ID: 915287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.
    Bianchino AC; Poon PH; Schumaker VN
    J Immunol; 1988 Dec; 141(11):3930-6. PubMed ID: 3183385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
    Giclas PC
    J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of C1 by soluble IgG aggregates as detected by a novel one-step hemolytic assay that specifically measures the proenzyme form of C1s.
    Doekes G; van Es LA; Daha MR
    J Immunol; 1983 Oct; 131(4):1924-9. PubMed ID: 6604753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the binding ability and the rate of activation of the complement component C1.
    Folkerd EJ; Gardner B; Hughes-Jones NC
    Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1 inactivator-C1s complexes in inflammatory joint disease.
    Inman RD; Harpel PC
    Clin Exp Immunol; 1983 Sep; 53(3):521-8. PubMed ID: 6604603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
    Gronski P; Bodenbender L; Kanzy EJ; Seiler FR
    Behring Inst Mitt; 1984 Nov; (76):29-41. PubMed ID: 6335396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E; Sorvillo J; Gigli I
    J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
    Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
    J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human C1: analysis with Western blotting reveals slow self-activation.
    Hosoi S; Circolo A; Borsos T
    J Immunol; 1987 Sep; 139(5):1602-8. PubMed ID: 3624867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism.
    Ziccardi RJ
    J Immunol; 1982 Jun; 128(6):2500-4. PubMed ID: 6281332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A simplified method for the assessment of C1 esterase inhibitor function].
    Deguchi M; Takemura S; Ueda M; Kasamatsu Y; Yanagida K; Fukuda W; Okamoto M; Onodera H; Sugino S; Kondo M
    Ryumachi; 1990 Jun; 30(3):166-71. PubMed ID: 2244251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
    Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
    Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.